avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zic2 | mm10_v2_chr14_+_122475397_122475435 | 0.22 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_52264323 Show fit | 11.13 |
ENSMUST00000039652.4
|
insulin I |
|
chr19_+_58728887 Show fit | 9.47 |
ENSMUST00000048644.5
|
pancreatic lipase related protein 1 |
|
chr7_-_142679533 Show fit | 7.65 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
insulin II |
|
chr6_-_41314700 Show fit | 5.05 |
ENSMUST00000064324.5
|
trypsin 5 |
|
chr8_-_105933832 Show fit | 3.96 |
ENSMUST00000034368.6
|
chymotrypsin-like |
|
chr1_-_37719782 Show fit | 2.83 |
ENSMUST00000160589.1
|
RIKEN cDNA 2010300C02 gene |
|
chr4_+_34893772 Show fit | 2.51 |
ENSMUST00000029975.3
ENSMUST00000135871.1 ENSMUST00000108130.1 |
glycoprotein hormones, alpha subunit |
|
chr4_-_141846359 Show fit | 2.51 |
ENSMUST00000037059.10
|
chymotrypsin C (caldecrin) |
|
chr4_-_141846277 Show fit | 2.42 |
ENSMUST00000105781.1
|
chymotrypsin C (caldecrin) |
|
chr9_+_111019284 Show fit | 2.02 |
ENSMUST00000035077.3
|
lactotransferrin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.5 | GO:0015758 | glucose transport(GO:0015758) |
2.5 | 7.6 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) neuron projection maintenance(GO:1990535) |
0.0 | 4.8 | GO:0007586 | digestion(GO:0007586) |
0.7 | 3.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 2.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 2.5 | GO:0006590 | thyroid hormone generation(GO:0006590) follicle-stimulating hormone secretion(GO:0046884) |
0.7 | 2.1 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 2.1 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.3 | 2.0 | GO:1902732 | antifungal humoral response(GO:0019732) positive regulation of chondrocyte proliferation(GO:1902732) |
0.6 | 1.9 | GO:0030221 | basophil differentiation(GO:0030221) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 17.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 11.9 | GO:0030141 | secretory granule(GO:0030141) |
0.3 | 7.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 5.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 2.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 2.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.5 | 2.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 2.0 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 1.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.4 | 1.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 22.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 18.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.6 | 10.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.3 | 3.4 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 1.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 1.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 1.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 2.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 2.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 2.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 2.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 2.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 2.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 2.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 1.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 1.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |